Evidence map›Paper›PMID 39627344›Full record

ArticleScientific reports2024

Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients.

Jie Wen, Yi Rong, Yinbo Kang, Dingyang Lv, Fan Cui, Huiyu Zhou, Mohan Jia, Qiwei Wang, Weibing Shuang

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jie WenDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Yi RongDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Yinbo KangDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Dingyang LvDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Fan CuiDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Huiyu ZhouDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Mohan JiaDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Qiwei WangDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China.
Weibing ShuangDepartment of Urology, First Hospital of Shanxi Medical University, No.85 Jiefang South Road, Yingze District, Taiyuan, Shanxi Province, China. shuangweibing@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell renal cell carcinoma (ccRCC) and ischemic stroke are critical global health challenges with a notable association. This study explores the correlation between tumor-related factors and ischemic stroke risk, aiming to construct a predictive nomogram model for ischemic stroke in ccRCC patients. We retrospectively analyzed data from ccRCC patients who underwent nephrectomy at the First Hospital of Shanxi Medical University between January 1, 2013, and May 31, 2022. The data were randomly divided into a training cohort (70%) and a validation cohort (30%). Predictive factors were identified using univariate logistic regression, least absolute shrinkage and selection operator regression, and multivariate logistic regression. A nomogram and a Shiny local calculator were developed using these predictors. We identified six predictors for the nomogram: WHO/ISUP grade, diabetes, hypertension, LDL-C, age, and D-dimer. The nomogram showed good discrimination, with an area under the ROC curve of 0.816 in the training cohort and 0.775 in the validation cohort. The optimal cutoff value was 53.7%. The model demonstrated excellent calibration and clinical applicability. WHO/ISUP grade correlates with ischemic stroke risk, offering insights into cancer-related ischemic stroke mechanisms. This nomogram aids in identifying high-risk individuals among ccRCC patients, facilitating early management and improved outcomes.

Indexed as

Carcinoma, Renal CellIschemic StrokeKidney NeoplasmsNomogramsAdultAgedFemaleHumansMaleMiddle AgedNephrectomyRetrospective StudiesRisk AssessmentRisk FactorsROC CurveClear cell renal cell carcinomaIschemic strokeNomogram

Identifiers

PMID39627344
PMCPMC11615042

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.